• Users Online: 19827
  • Home
  • Print this page
  • Email this page
This article has been cited by
1Response to comment on: Rebound inflammation after an intravitreal injection in Vogt–Koyanagi–Harada syndrome
Richa Ranjan,Manisha Agarwal
Indian Journal of Ophthalmology.2018;66(10)1523
[DOI]
2Murphy’s Law and Ophthalmic Complications in a Patient With Type 1 Diabetes Mellitus
Zineb Barkhane,Maria Qureshi,Ahmed Jamil,Purnashree Chowdhury,Muhammad Kamran,Mohamedalamin Alnoor Altayb Ismail,Shahzeb Saeed
Cureus.2023;66(10)1523
[DOI]
3Ophthalmic biosimilars and biologics—role of endotoxins
Ashish Sharma,Nilesh Kumar,Baruch D. Kuppermann,Francesco Bandello,Anat Loewenstein
Eye.2020;34(4)614
[DOI]
4Safety, sterility and stability of direct-from-vial multiple dosing intravitreal injection of bevacizumab
Taraprasad Das,Srinivas Volety,Saad M Ahsan,Abhay K Thakur,Savitri Sharma,Tapas R Padhi,Soumyava Basu,Ch Mohan Rao
Clinical & Experimental Ophthalmology.2015;43(5)466
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal